Duloxetine
Product Images NDC 64725-0747

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 64725-0747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0747)

This is a description of a medication called Duloxetine DR 30mg capsule, which has been repackaged by T.Y.A. Pharmaceuticals. The medication is intended for prescription use only and comes in a bottle with 80 capsules. The bottle has a specific lot number and expiration date. The manufacturer of the medication is Laboratorios Dreste. The package insert should be consulted for dosage information.*

FDA Label Image

Chemical Structure (Duloxetine 01)

FDA Label Image

Figure 1 (Duloxetine 02)

FDA Label Image

Figure 2 (Duloxetine 03)

FDA Label Image

Figure 3 (Duloxetine 04)

This image shows the percentage of patients who have improved in a study. It compares a placebo to a drug called CYM80/120 mg taken once daily. The x-axis indicates the percent improvement in pain from baseline (BOCF) and the y-axis shows the percentage of patients. The graph shows that a higher percentage of patients taking CYM80/120 mg had improved pain compared to those taking the placebo.*

FDA Label Image

Figure 4 (Duloxetine 05)

This is a graph displaying the percentage of patients improved in pain from baseline with a placebo and CYM60 mg once daily. The x-axis shows the percent improvement in pain ranging from 0 to 100, and the y-axis shows the percentage of patients. The placebo group showed a 100% improvement in pain, while the CYM60 mg once daily group showed an improvement of 80%.*

FDA Label Image

Figure 5 (Duloxetine 06)

This document appears to be a graph illustrating the percentage of patients who showed improvement in pain from baseline in a clinical trial. The x-axis shows different levels of pain improvement represented by numbers ranging from 0 to 100. The y-axis shows the percentage of patients who experienced that level of improvement. Two different lines are plotted on the graph: one for patients who received a placebo and another for patients who received a medication referred to as CYM60/120 mg once daily. There is no further information available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.